9 months ago
INSM
AnalystsTiago FauthTiago Fauth's Stock Forecasts
AnalystsTiago Fauth
Sectors:
Analyst Ranking
Top 15%
#804 out of 5327 analysts
Average Return
+8.8%
Win Rate
42%59 out of 139
Risk vs Reward
Poor
Good
Tiago Fauth's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Liquidia CorpLQDA | +395.67% | $14.45 | $71.63 | 2025-06-12 - 2026-06-11 | Strong Buy |
Liquidia CorpLQDA | +337.57% | $14.18 | $62.03 | 2025-05-28 - 2026-05-27 | Strong Buy |
Absci CorpABSI | +312.39% | $1.17 | $4.83 | 2023-05-16 - 2024-05-15 | Buy |
Prometheus Biosciences IncRXDX | +299.88% | $48.39 | $193.50 | 2022-08-12 - 2023-04-18 | Buy |
Verona Pharma PLCVRNA | +240.31% | $30.81 | $104.85 | 2024-10-03 - 2025-07-10 | Strong Buy |
Tiago Fauth Analyst Color
Get additional color on Tiago Fauth's coverage of popular stocks
Tiago Fauth's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Tonix Pharmaceuticals Holding CorpTNXP | 1 | Strong Buy | $26.00 | +136.79% | Initiates Coverage On | a month ago |
Maplight Therapeutics IncMPLT | 1 | Strong Buy | $46.00 | +27.81% | Initiates Coverage On | a month ago |
Insmed IncINSM | 9 | Strong Buy | $217.00 | +102.77% | Maintains | 9 months ago |
Wave Life Sciences LtdWVE | 4 | Strong Buy | $18.00 | +214.14% | Maintains | a year ago |
United Therapeutics CorpUTHR | 7 | Hold | $414.00 | -21.79% | Maintains | a year ago |
Mannkind CorpMNKD | 2 | Strong Buy | $10.00 | +151.26% | Maintains | a year ago |
Ptc Therapeutics IncPTCT | 5 | Strong Buy | $73.00 | -6.42% | Maintains | a year ago |
Liquidia CorpLQDA | 3 | Strong Buy | $31.00 | -59.78% | Maintains | a year ago |
Alnylam Pharmaceuticals IncALNY | 7 | Hold | $395.00 | +44.86% | Maintains | a year ago |
Ultragenyx Pharmaceutical IncRARE | 8 | Strong Buy | $65.00 | N/A | Maintains | a year ago |
Verona Pharma PLCVRNA | 7 | Hold | $107.00 | N/A | Downgrades | a year ago |
Bridgebio Pharma IncBBIO | 1 | Strong Buy | $76.00 | N/A | Maintains | a year ago |
Savara IncSVRA | 2 | Strong Buy | $7.00 | N/A | Maintains | a year ago |
Inozyme Pharma IncINZY | 3 | Hold | $4.00 | N/A | Downgrades | a year ago |
Tectonic Therapeutic IncTECX | 4 | Strong Buy | $101.00 | N/A | Maintains | a year ago |
Pliant Therapeutics IncPLRX | 2 | Hold | $3.00 | N/A | Maintains | a year ago |
Keros Therapeutics IncKROS | 6 | Strong Buy | $26.00 | N/A | Maintains | a year ago |
Amicus Therapeutics IncFOLD | 1 | Strong Buy | $17.00 | N/A | Maintains | a year ago |
Disc Medicine IncIRON | 1 | Strong Buy | $75.00 | N/A | Initiates Coverage On | 2 years ago |
Jade Biosciences IncJBIO | 2 | Hold | $70.00 | N/A | Downgrades | 2 years ago |
Ventyx Biosciences IncVTYX | 5 | Buy | $62.00 | N/A | Maintains | 3 years ago |
Ascendis Pharma AASND | 13 | Hold | $89.00 | N/A | Assumes | 3 years ago |
Viridian Therapeutics IncVRDN | 3 | Buy | $51.00 | N/A | Assumes | 3 years ago |
Biomarin Pharmaceutical IncBMRN | 7 | Buy | $120.00 | N/A | Assumes | 3 years ago |
23andme Holding CoMEHCQ | 6 | Buy | $120.00 | N/A | Reiterates | 3 years ago |
Immunovant IncIMVT | 4 | Sell | $4.00 | N/A | Reiterates | 3 years ago |
Vectivbio Holding AgVECT | 2 | Hold | $17.00 | N/A | Downgrades | 3 years ago |
Absci CorpABSI | 4 | Buy | $14.00 | N/A | Reiterates | 3 years ago |
Spruce Biosciences IncSPRB | 3 | Buy | $4.00 | N/A | Reiterates | 3 years ago |
Kura Oncology IncKURA | 5 | Buy | $26.00 | N/A | Reiterates | 3 years ago |
Abcellera Biologics IncABCL | 7 | Buy | $28.00 | N/A | Maintains | 3 years ago |
Apellis Pharmaceuticals IncAPLS | 9 | Hold | $81.00 | N/A | Maintains | 3 years ago |
Prometheus Biosciences IncRXDX | 5 | Hold | $200.00 | N/A | Downgrades | 3 years ago |
Humanigen IncHGENQ | 3 | Sell | $0.50 | N/A | Reiterates | 3 years ago |
Bioatla IncBCAB | 5 | Hold | $400.00 | N/A | Reiterates | 3 years ago |
Pyxis Oncology IncPYXS | 2 | Buy | $14.00 | N/A | Reiterates | 3 years ago |
Alx Oncology Holdings IncALXO | 2 | Buy | $34.00 | N/A | Maintains | 3 years ago |
Damora Therapeutics IncDMRA | 2 | Buy | $150.00 | N/A | Reiterates | 3 years ago |
Exelixis IncEXEL | 1 | Buy | $29.00 | N/A | Initiates Coverage On | 3 years ago |
Omniab IncOABI | 1 | Buy | $13.00 | N/A | Initiates Coverage On | 4 years ago |
Editas Medicine IncEDIT | 2 | Hold | $13.00 | N/A | Downgrades | 4 years ago |
Forma Therapeutics Holdings IncFMTX | 2 | Hold | $20.00 | N/A | Downgrades | 4 years ago |
Inflarx NvIFRX | 3 | Sell | $2.00 | N/A | Maintains | 4 years ago |
Argenx SeARGX | 2 | Hold | $340.00 | N/A | Maintains | 5 years ago |
Iveric Bio IncISEE | 1 | Buy | $18.00 | N/A | Maintains | 5 years ago |
Arena Pharmaceuticals IncARNA | 1 | Buy | $98.00 | N/A | Maintains | 5 years ago |
Amgen IncAMGN | 1 | Buy | $259.00 | N/A | Maintains | 5 years ago |
Intercept Pharmaceuticals IncICPT | 1 | Hold | $59.00 | N/A | Downgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.